Keating Investment Counselors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Hold
6,182
0.1% 46
2026
Q1
$375K Sell
6,182
-655
-10% -$38.2K 0.09% 46
2025
Q4
$369K Sell
6,837
-20
-0.3% -$962 0.1% 50
2025
Q3
$309K Sell
6,857
-1,560
-19% -$72.9K 0.09% 55
2025
Q2
$390K Sell
8,417
-3,000
-26% -$147K 0.12% 50
2025
Q1
$696K Hold
11,417
0.21% 45
2024
Q4
$646K Buy
11,417
+2,660
+30% +$149K 0.2% 44
2024
Q3
$453K Sell
8,757
-1,600
-15% -$75.1K 0.14% 49
2024
Q2
$430K Sell
10,357
-1,255
-11% -$56.2K 0.14% 51
2024
Q1
$630K Sell
11,612
-8,425
-42% -$429K 0.2% 50
2023
Q4
$1.03M Sell
20,037
-100
-0.5% -$5.25K 0.37% 51
2023
Q3
$1.17M Hold
20,137
0.4% 39
2023
Q2
$1.29M Sell
20,137
-1,300
-6% -$87.2K 0.47% 38
2023
Q1
$1.49M Buy
21,437
+100
+0.5% +$7.05K 0.56% 36
2022
Q4
$1.54M Buy
21,337
+1,700
+9% +$128K 0.6% 36
2022
Q3
$1.4M Sell
19,637
-50
-0.3% -$3.63K 0.63% 33
2022
Q2
$1.52M Sell
19,687
-150
-0.8% -$11.4K 0.64% 33
2022
Q1
$1.45M Sell
19,837
-100
-0.5% -$6.71K 0.62% 38
2021
Q4
$1.24M Hold
19,937
0.55% 39
2021
Q3
$1.18M Sell
19,937
-100
-0.5% -$6.59K 0.55% 37
2021
Q2
$1.34M Hold
20,037
0.61% 36
2021
Q1
$1.26M Sell
20,037
-1,975
-9% -$123K 0.61% 34
2020
Q4
$1.36M Hold
22,012
0.68% 33
2020
Q3
$1.33M Sell
22,012
-200
-0.9% -$12K 0.69% 32
2020
Q2
$1.31M Hold
22,212
0.72% 30
2020
Q1
$1.24M Hold
22,212
0.76% 30
2019
Q4
$1.43M Sell
22,212
-60
-0.3% -$3.44K 0.62% 38
2019
Q3
$1.13M Sell
22,272
-2,050
-8% -$96.3K 0.51% 40
2019
Q2
$1.1M Hold
24,322
0.49% 43
2019
Q1
$1.16M Sell
24,322
-600
-2% -$29.9K 0.52% 43
2018
Q4
$1.29M Hold
24,922
0.66% 38
2018
Q3
$1.55M Sell
24,922
-1,300
-5% -$77.1K 0.67% 38
2018
Q2
$1.45M Sell
26,222
-300
-1% -$16.2K 0.69% 37
2018
Q1
$1.68M Sell
26,522
-3,360
-11% -$216K 0.77% 37
2017
Q4
$1.83M Hold
29,882
0.78% 37
2017
Q3
$1.91M Sell
29,882
-200
-0.7% -$11.7K 0.83% 37
2017
Q2
$1.68M Hold
30,082
0.73% 38
2017
Q1
$1.64M Sell
30,082
-8,100
-21% -$444K 0.73% 36
2016
Q4
$2.23M Sell
38,182
-175
-0.5% -$9.57K 1.05% 33
2016
Q3
$2.07M Sell
38,357
-1,690
-4% -$109K 1.01% 32
2016
Q2
$2.94M Sell
40,047
-7,057
-15% -$499K 1.44% 29
2016
Q1
$3.01M Sell
47,104
-44,012
-48% -$2.78M 1.47% 29
2015
Q4
$6.27M Sell
91,116
-895
-1% -$59.1K 3.14% 11
2015
Q3
$5.45M Sell
92,011
-890
-1% -$56.5K 2.93% 13
2015
Q2
$6.18M Sell
92,901
-1,535
-2% -$101K 3.15% 11
2015
Q1
$6.09M Sell
94,436
-1,800
-2% -$113K 3.05% 11
2014
Q4
$5.68M Sell
96,236
-290
-0.3% -$16.4K 2.83% 13
2014
Q3
$4.94M Sell
96,526
-3,708
-4% -$185K 2.55% 20
2014
Q2
$4.86M Sell
100,234
-1,250
-1% -$61.6K 2.34% 23
2014
Q1
$5.27M Sell
101,484
-9,193
-8% -$489K 2.63% 17
2013
Q4
$5.88M Sell
110,677
-8,450
-7% -$430K 3% 15
2013
Q3
$5.51M Sell
119,127
-3,475
-3% -$153K 3.07% 15
2013
Q2
$5.48M Buy
+122,602
New +$5.32M 3.09% 14

Other funds holding BMY

Keating Investment Counselors's BMY Position: Q2 2026 in Review

Keating Investment Counselors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,182 shares worth $356K. The position accounts for 0.1% of the portfolio, ranked #46.

Keating Investment Counselors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.27M in Q4 2015. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Keating Investment Counselors held 6,182 shares of Bristol-Myers Squibb worth $356K as of Q2 2026.
  • Keating Investment Counselors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.1% of Keating Investment Counselors's portfolio in Q2 2026, its #46 holding.
  • Keating Investment Counselors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Keating Investment Counselors's Bristol-Myers Squibb position peaked at $6.27M in Q4 2015.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Keating Investment Counselors's 13F filing for Q2 2026, filed 16 Jul 2026.